Related Experiment Videos
Late failures of trabeculoplasty
International Ophthalmology
|February 1, 1987
Summary
Argon laser trabeculoretraction (A.L.T.R.) shows decreasing efficacy over time, with failure rates increasing annually. This glaucoma treatment offers limited reduction in medical therapy needs.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Surgical Interventions
Background:
- Glaucoma management often involves surgical interventions to lower intraocular pressure (IOP).
- Argon laser trabeculoretraction (A.L.T.R.) is a procedure used to treat certain types of glaucoma.
- Long-term efficacy and failure rates of A.L.T.R. require continued investigation.
Purpose of the Study:
- To evaluate the long-term effectiveness and failure rates of Argon laser trabeculoretraction (A.L.T.R.) in glaucoma patients.
- To assess the impact of A.L.T.R. on the need for medical therapy.
- To identify patient subgroups and glaucoma types with varying responses to A.L.T.R.
Main Methods:
- A longitudinal study involving 151 phakic patients (25-93 years old) treated with A.L.T.R.
- Follow-up periods of two, three, and four years were conducted.
- Intraocular pressure (IOP) reduction and failure rates were recorded and analyzed.
Main Results:
- Two-year follow-up: 6.93 mmHg IOP drop, 28% failure rate.
- Three-year follow-up: 6.30 mmHg IOP drop, 36% failure rate.
- Four-year follow-up: 7.87 mmHg IOP drop, 41% failure rate. Less than 50% reduction in medical therapy. Higher failure rates in advanced glaucoma. Variable efficacy across different glaucoma types.
Conclusions:
- A.L.T.R. demonstrates increasing failure rates with longer follow-up periods.
- The procedure provides limited success in reducing the need for concurrent medical treatment.
- Efficacy varies significantly among different glaucoma subtypes, with poorer outcomes in myopic and aphakic glaucoma.